BPC-157 and Clascoterone Interaction

Q: Can I take BPC-157 with Clascoterone?

Yes, BPC-157 and Clascoterone can generally be taken together. Both BPC-157 and Clascoterone promote collagen synthesis. Complementary mechanisms may enhance connective tissue repair and skin quality.

Q: Is BPC-157 and Clascoterone safe together?

Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: teratogenic. Monitor accordingly.

Q: How should I time BPC-157 and Clascoterone?

BPC-157 has a half-life of <30 minutes and Clascoterone has a half-life of Short topical (local action; rapidly metabolized to cortexolone). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Synergistic

Mechanism-based 45% confidence

BPC-157 and Clascoterone have a synergistic interaction with 45% confidence. Both BPC-157 and Clascoterone promote collagen synthesis. Complementary mechanisms may enhance connective tissue repair and skin quality. These compounds primarily affect different organ systems.

Compound Profiles

BPC-157

Body Protection Compound-157 | Pentadecapeptide

Promotes blood vessel formation (angiogenesis), enhances collagen synthesis, modulates growth factor expression including VEGF, and protects against tissue damage through localized or systemic delivery pathways..

Half-life: <30 minutes Typical dose: 250-500mcg healing, longevity

vegf anticoagulantcarcinogenic riskpro angiogenicteratogenic

View full profile

Clascoterone

Topical Androgen Receptor Inhibitor | Acne & Hair Loss

Clascoterone acts as a competitive antagonist of the androgen receptor (AR). When applied topically, it penetrates the skin and binds directly to androgen receptors in target tissues -- sebaceous glands (for acne) and dermal papilla cells of hair follicles (for alopecia).

Half-life: Short topical (local action; rapidly metabolized to cortexolone) Typical dose: Acne: 1% cream 2x/day | Hair loss: 7.5% solution once daily hair loss, skin

androgen receptorngf androgenicteratogenic

View full profile

Combined Organ Load

Blood Vessels

low

Skin

low

Shared Safety Flags

2x 2 compounds share the teratogenic safety flag (BPC-157, Clascoterone). Monitor accordingly.

Frequently Asked Questions

Can I take BPC-157 with Clascoterone?

Yes, BPC-157 and Clascoterone can generally be taken together. Both BPC-157 and Clascoterone promote collagen synthesis. Complementary mechanisms may enhance connective tissue repair and skin quality.

Is BPC-157 and Clascoterone safe together?

Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: teratogenic. Monitor accordingly.

What are the interactions between BPC-157 and Clascoterone?

Both BPC-157 and Clascoterone promote collagen synthesis. Complementary mechanisms may enhance connective tissue repair and skin quality. This assessment has 45% confidence and is inferred from pharmacological mechanism analysis.

How should I time BPC-157 and Clascoterone?

BPC-157 has a half-life of <30 minutes and Clascoterone has a half-life of Short topical (local action; rapidly metabolized to cortexolone). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: BPC-157 vs Clascoterone

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.